Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults |
Cryptosporidiosis | Phase2 | United States | NCT07249463 |
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis |
Secondary Progressive Multiple Sclerosis (SPMS) | Phase3 | Argentina Australia Austria Bulgaria Canada China Colombia Czechia Denmark France Germany Greece Hungary India Israel Italy Netherlands Poland Portugal Romania Slovakia South Africa Spain Switzerland United Kingdom United States View all |
NCT07225504 |
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia |
Breast Cancer | Russia | NCT06930859 | |
A Study of DII235 in Adults With Elevated Lipoprotein(a) |
Lipoprotein Disorder | Phase2 | China Germany Japan United States View all |
NCT07235046 |
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer |
Metastatic Castration Resistant Prostate Cancer | Italy | NCT07093801 | |
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients |
Myocardial Infarction | Russia | NCT07142265 | |
Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients |
Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase3 | Brazil Colombia Germany Italy Netherlands United States View all |
NCT06934967 |
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN |
Primary Immunoglobulin A Nephropathy (IgAN) | Phase3 | Australia China Hong Kong Israel Japan United States View all |
NCT06994845 |
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes |
Acute Coronary Syndrome | Phase3 | Australia Canada China France Germany Hong Kong Hungary India Japan Poland South Korea Spain Switzerland View all |
NCT07102628 |
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors |
Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer, Colorectal Cancer, Soft Tissue Sarcoma | Phase1 | Canada Denmark France Germany Israel Singapore View all |
NCT07261631 |